Toxicity Management of Front-Line Pembrolizumab + Axitinib in Clear Cell mRCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Toxicity Management of Front-Line Pembrolizumab Combined With Axitinib in Clear Cell Metastatic Renal Cell Carcinoma: A Case Study Approach
JCO Oncol Pract 2020 Feb 01;16(2_suppl)15s-19s, LS Wood, MC OrnsteinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.